This article reviews recent clinical trials evaluating the safety and efficacy of stem cell therapies for patients suffering from Long COVID. It highlights the potential of mesenchymal stem cells (MSCs) to reduce inflammation and promote tissue repair, showing promising results in improving symptoms such as fatigue and respiratory issues.
Menu
